Atossa Therapeutics
ATOS
#9237
Rank
A$0.15 B
Marketcap
A$1.20
Share price
5.24%
Change (1 day)
-35.32%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -A$44.23 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$38.4 Million, an increase over its 2023 earnings that were of -A$45.31 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$44.23 Million15.18%
2024 -A$38.4 Million-15.25%
2023 -A$45.31 Million11.62%
2022 -A$40.59 Million30.84%
2021 -A$31.03 Million15.58%
2020 -A$26.84 Million3.41%
2019 -A$25.96 Million51.16%
2018 -A$17.18 Million40.41%
2017 -A$12.23 Million27.54%
2016 -A$9.59 Million-47.49%
2015 -A$18.26 Million-17.25%
2014 -A$22.07 Million35.91%
2013 -A$16.24 Million112.3%
2012 -A$7.65 Million46.53%
2011 -A$5.22 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$48.77 B-112,907.30%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$2.00 B-4,742.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$1.93 B-4,581.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-A$11.81 Million-72.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
A$62.75 M-245.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-A$0.17 Billion 280.29%๐Ÿ‡บ๐Ÿ‡ธ USA